drugset / Trial / NCT03984045
SPG Block for Acute Pediatric Migraine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2% lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10 years of age presenting to a pediatric emergency department with an acute frontal migraine headache.
Timeline
- Start
- 2019-06-06
- Primary completion
- 2022-06-30
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 % | Intranasal |
| Comparator | Prochlorperazine | Small molecule | 0.15 mg/kg | Intravenous |